JOHAN (THIJS) SPOOR

Corporate Board Profile

Tech Score: 0/100

Perspective Therapeutics, Inc.

Filing Date	Source Excerpt
2023-08-22	Johan (Thijs) Spoor has been a director of the Company and has served as our Chief Executive Officer since February 5, 2023... Mr. Spoor was appointed as a director in connection with the merger with Viewpoint Molecular Targeting, Inc.... Our Board of Directors believes that Mr. Spoor’s experience as our Chief Executive Officer and experience as an established leader with nearly 30 years of combined executive, broad management and capital markets expertise across healthcare and medical device industries qualifies him to serve on our Board... Employee directors do not receive any compensation for their service on the Board.
2024-04-18	Mr. Spoor holds a Pharmacy degree from the University of Toronto and an MBA from Columbia Business School. Our Board of Directors believes that Mr. Spoor’s experience as our Chief Executive Officer and experience as an established leader with nearly 30 years of combined executive, broad management and capital markets expertise across healthcare and medical device industries qualifies him to serve on our Board.

Filing Date

Source Excerpt

2023-08-22

Johan (Thijs) Spoor has been a director of the Company and has served as our Chief Executive Officer since February 5, 2023... Mr. Spoor was appointed as a director in connection with the merger with Viewpoint Molecular Targeting, Inc.... Our Board of Directors believes that Mr. Spoor’s experience as our Chief Executive Officer and experience as an established leader with nearly 30 years of combined executive, broad management and capital markets expertise across healthcare and medical device industries qualifies him to serve on our Board... Employee directors do not receive any compensation for their service on the Board.

2024-04-18

Mr. Spoor holds a Pharmacy degree from the University of Toronto and an MBA from Columbia Business School. Our Board of Directors believes that Mr. Spoor’s experience as our Chief Executive Officer and experience as an established leader with nearly 30 years of combined executive, broad management and capital markets expertise across healthcare and medical device industries qualifies him to serve on our Board.

Data sourced from SEC filings. Last updated: 2025-08-30